News from medicago inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Feb 25, 2015, 07:26 ET

US-amerikanisches Ministerium für Gesundheitspflege und Soziale Dienste beauftragt Medicago mit der Erkundung alternativer Methoden zur Produktion von Ebola-Antikörpern

Medicago, ein führendes Unternehmen im Bereich der Entwicklung und Produktion von pflanzlichen Impfstoffen und Therapeutika, gab heute...

Feb 24, 2015, 15:01 ET

Medicago explorará métodos de producción alternativos para los anticuerpos del Ébola

- Medicago recibe un contrato del Departamento de EE. UU. de Salud y Servicios Humanos para explorar métodos de producción alternativos...

Feb 24, 2015, 12:02 ET

Medicago décroche un contrat de l'U.S. Department of Health and Human Services pour étudier des méthodes alternatives de production d'anticorps contre l'Ébola

Medicago, chef de file dans le développement et la production de vaccins et de médicaments sur plantes, a annoncé aujourd'hui avoir...

Feb 24, 2015, 09:40 ET

Medicago awarded a contract by the U.S. Department of Health and Human Services to explore alternate production methods for Ebola antibodies

QUEBEC CITY, Feb. 24, 2015 /PRNewswire/ - Medicago, a leading company in the development and production of plant-based vaccines and therapeutics,...

Sep 18, 2013, 07:50 ET

Mitsubishi Tanabe Pharma Completes Acquisiton of Medicago

OSAKA, Japan and QUEBEC CITY, Canada, Sept. 18, 2013 /PRNewswire/ - Mitsubishi Tanabe Pharma Corporation (TSE: 4508) ("Mitsubishi Tanabe Pharma"...

Sep 12, 2013, 07:00 ET

Medicago Announces Receipt of Final Court Order and Regulatory Approvals for Arrangement with Mitsubishi Tanabe Pharma

QUEBEC CITY, Sept. 12, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF) ("Medicago" or the "Company"), a biopharmaceutical company...

Aug 29, 2013, 14:33 ET

Medicago Shareholders Approve Arrangement with Mitsubishi Tanabe Pharma Corporation

QUEBEC CITY, Aug. 29, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF) ("Medicago" or the "Company"), a biopharmaceutical company...

Aug 19, 2013, 07:00 ET

Medicago Inc. announces leading independent proxy firms recommend voting in favour of the arrangement with Mitsubishi Tanabe Pharma

QUEBEC CITY, Aug. 19, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF) ("Medicago"), a biopharmaceutical company focused on developing...

Aug 09, 2013, 17:00 ET

Medicago Announces 2013 Second Quarter Financial Results

QUEBEC CITY, Aug. 9, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG), a biopharmaceutical company focused on developing highly effective and...

Jul 31, 2013, 18:38 ET

Medicago announces special meeting of shareholders to be held on August 29, 2013 to approve the Transaction with Mitsubishi Tanabe Pharma

QUEBEC CITY, July 31, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF) ("Medicago"), a biopharmaceutical company focused on developing...

Jul 12, 2013, 03:09 ET

Medicago announces agreement to be acquired by Mitsubishi Tanabe Pharma in a transaction valued at $357M

QUÉBEC CITY, July 12, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly...

Jun 27, 2013, 15:09 ET

Immune Design and Medicago Announce License Agreement and Collaboration to Develop Novel Adjuvanted Pandemic Influenza Vaccines

SEATTLE and QUEBEC CITY, June 27, 2013 /PRNewswire/ - Immune Design, a leader in the field of therapeutic vaccines for cancer, infectious...

Jun 20, 2013, 07:00 ET

Medicago successfully produces plant-based Rotavirus VLP vaccine candidate

-First successful plant-based Rotavirus VLP containing all 4 Major proteins- -International Patent Application filed- QUEBEC CITY, June 20,...

Jun 17, 2013, 07:00 ET

Medicago Granted Patent for Influenza Virus-Like Particles in Plants

QUEBEC CITY, June 17, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly...

Jun 11, 2013, 07:00 ET

Medicago Receives Authorization from Health Canada and Commences Phase II Clinical Trial for an H5N1 Vaccine

QUEBEC CITY, June 11, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly...

Jun 06, 2013, 07:04 ET

Medicago is First in the World to Report Positive Interim Results for its H7N9 Pre-Clinical Trial

- The H7 VLP vaccine candidate induces an antibody response after a single dose in mice- QUEBEC CITY, June 6, 2013 /PRNewswire/ - Medicago Inc....

May 09, 2013, 17:05 ET

Medicago Announces 2013 First Quarter Financial Results

QUEBEC CITY, May 9, 2013 /PRNewswire/ -   Medicago Inc. (TSX: MDG), a biopharmaceutical company focused on developing highly effective and...

May 08, 2013, 07:00 ET

Medicago successfully produces VLP vaccine candidate for H7N9 virus responsible for recent influenza outbreak in China

-Medicago Ready to Collaborate with Authorities to Further Study the Potential of this Vaccine to Protect Against H7N9- QUEBEC CITY, May 8, 2013...

Apr 17, 2013, 14:45 ET

Medicago and IDRI Reports Positive Results for its Phase I Clinical Trial for an H5N1 Vaccine

- All three configurations of adjuvant and route of administration exceeded the three CHMP criteria- QUEBEC CITY, and SEATTLE, WA, April 17,...

Apr 09, 2013, 07:00 ET

Medicago and IDRI to present data at the World Vaccine Congress

-Presentation of Positive Interim Phase I Clinical Trial results for an H5N1 Vaccine with GLA Adjuvant- QUEBEC CITY, and SEATTLE, WA, April 9,...